ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,781 | +77.4% | 13,518 | +59.2% | 0.00% | – |
| Q2 2023 | $87,267 | -44.9% | 8,489 | -58.6% | 0.00% | – |
| Q1 2023 | $158,399 | +38.9% | 20,518 | +32.3% | 0.00% | – |
| Q4 2022 | $114,006 | -99.8% | 15,511 | +136.0% | 0.00% | – |
| Q3 2022 | $47,318,000 | +59.7% | 6,572 | +88.7% | 0.00% | – |
| Q2 2022 | $29,632,000 | -12.5% | 3,482 | -7.8% | 0.00% | – |
| Q1 2022 | $33,880,000 | -24.6% | 3,777 | +16.4% | 0.00% | – |
| Q4 2021 | $44,957,000 | +99.1% | 3,246 | +53.4% | 0.00% | – |
| Q3 2021 | $22,578,000 | +460.0% | 2,116 | +372.3% | 0.00% | – |
| Q2 2021 | $4,032,000 | – | 448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $27,257,000 | 2.19% |
| Omega Fund Management, LLC | 1,284,900 | $13,620,000 | 1.29% |
| Samsara BioCapital, LLC | 399,190 | $4,231,000 | 0.78% |
| Soleus Capital Management, L.P. | 313,064 | $3,318,000 | 0.60% |
| Avidity Partners Management LP | 1,511,000 | $16,017,000 | 0.44% |
| Dorsey Wright & Associates | 3,380 | $35,828,000 | 0.42% |
| EcoR1 Capital, LLC | 741,290 | $7,858,000 | 0.35% |
| Orbimed Advisors | 3,070,955 | $32,552,000 | 0.30% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,460,000 | 0.29% |
| DAFNA Capital Management LLC | 113,302 | $1,201,000 | 0.28% |